Hinge Health, Inc. has reported a series of stock sales by its Chief Financial Officer, Budge James, as detailed in a recent SEC filing. This event is notable as it may indicate changes in executive holdings and could reflect broader trends within the computer processing and data preparation industry.

Background

Hinge Health, Inc. operates in the technology sector, specifically under the SIC classification of Services-Computer Processing & Data Preparation (7374). The company trades on the NYSE under the ticker symbol HNGE. Recent filings show that it is categorized as a non-accelerated filer and an emerging growth company.

What the Filing Says

According to the SEC filing dated November 12, 2026, Budge James conducted multiple transactions involving the sale of Class A Common Stock on November 10, 2026. The sales included:

  • 1,900 shares at a price of $119.52
  • 7,601 shares at a price of $120.69
  • 15,899 shares at a price of $121.36
  • 4,925 shares at a price of $122.75
  • 5,582 shares at a price of $123.34

Following these transactions, James retained ownership of 256,207 shares of Hinge Health.

Impact

This series of transactions may impact various stakeholders, including investors and analysts monitoring Hinge Health's executive actions. The sales were executed under a Rule 10b5-1 trading plan, which allows executives to sell shares in a structured manner, potentially reducing the risk of insider trading allegations.

What's Next

The filing does not say what happens next.